Below are the most recent publications written about "Thrombosis" by people in Profiles.
-
Kulkarni PP, Alluri RK, Godwin M, Forbes GL, Merkulova A, Lambert S, Vijay A, Palihati M, Kundu S, Shim YJ, Kalonji K, Schmaier AH, Holinstat M, Cameron SJ, McCrae KR. Protection of ?2GPI-deficient mice from thrombosis reflects a defect in PAR3-facilitated platelet activation. Blood. 2025 May 01; 145(18):2086-2099.
-
Strauss JD, Gilbert MR, Mehta M, Li A, Zhou R, Bondy ML, Sulman EP, Yuan Y, Liu Y, Vera E, Wendland MM, Stieber VW, Puduvalli VK, Choi S, Martinez NL, Robins HI, Hunter GK, Lin CF, Guedes VA, Richard MA, Pugh SL, Armstrong TS, Scheurer ME. Clinical and genetic markers of vascular toxicity in glioblastoma patients: Insights from NRG Oncology RTOG-0825. Neuro Oncol. 2025 Mar 07; 27(3):767-778.
-
Yadav VK, Sharma S, Maurya S, Singh RK, Saini J, Jain P, Patir R, Ahlawat S, Das S, Vaishya S, Agarwal S, Singh A, Gupta RK. Presence of Fragmented Intratumoral Thrombosed Microvasculature in the Necrotic and Peri-Necrotic Regions on SWI Differentiates IDH Wild-Type Glioblastoma From IDH Mutant Grade 4 Astrocytoma. J Magn Reson Imaging. 2025 Jul; 62(1):258-270.
-
Leung HHL, Ahmadi Z, Lee B, Casey J, Ratnasingam S, McKenzie SE, Perdomo J, Chong BH. Antithrombotic efficacy and bleeding risks of vaccine-induced immune thrombotic thrombocytopenia treatments. Blood Adv. 2024 11 26; 8(22):5744-5752.
-
Goerger K, Caldwell M, Biermann G, Besh F, Flickema T, Patel P, Abbott K, Holinstat M, Larson MK. Observational Analyses of Ex Vivo Native American Platelet Responses. Int J Mol Sci. 2024 Nov 08; 25(22).
-
Wurtzel JGT, Gray BD, Pak KY, Zhao X, Ma P, McKenzie SE, Tanujaya M, Rizzo V, Del Carpio-Cano F, Rao AK, Lee-Gau Chong P, Goldfinger LE. Phosphatidylserine-blocking nanoparticles inhibit thrombosis without increased bleeding in mice. J Thromb Haemost. 2025 Jan; 23(1):108-122.
-
Halawi H, Sabawi MM, Rizk E, Mahmoud AA, Petkova JH, Hui SR, Srour N, Donahue KR. Bleeding outcomes in critically ill patients on heparin with discordant aPTT and anti-Xa activity. J Thromb Thrombolysis. 2025 Feb; 58(2):210-219.
-
Wisniewski A, Norman A, Tsang S, Ricketts R, Sharma R, Suggs J, Vizzini S, Castro B, Raphael J, McNaull P, Gangemi J, Roeser M, Mazzeffi M. Pilot Assessment of Platelet Thrombus Area and Contractile Force in Pediatric Congenital Heart Surgery Patients Using a Microfluidic Device. J Cardiothorac Vasc Anesth. 2024 Sep; 38(9):2009-2016.
-
Hollis IB, Jennings DL, Krim S, Ton VK, Ducharme A, Cowger J, Looby M, Eulert-Green JJ, Bansal N, Horn E, Byku M, Katz J, Michaud CJ, Rajapreyar I, Campbell P, Vale C, Cosgrove R, Hernandez-Montfort J, Otero J, Ingemi A, Raj S, Weeks P, Agarwal R, Martinez ES, Tops LF, Ahmed MM, Kiskaddon A, Kremer J, Keebler M, Ratnagiri RK. An ISHLT consensus statement on strategies to prevent?and manage hemocompatibility related adverse events in patients with a durable, continuous-flow ventricular assist device. J Heart Lung Transplant. 2024 Aug; 43(8):1199-1234.
-
Poscablo DM, Worthington AK, Smith-Berdan S, Rommel MGE, Manso BA, Adili R, Mok L, Reggiardo RE, Cool T, Mogharrab R, Myers J, Dahmen S, Medina P, Beaudin AE, Boyer SW, Holinstat M, Jonsson VD, Forsberg EC. An age-progressive platelet differentiation path from hematopoietic stem cells causes exacerbated thrombosis. Cell. 2024 Jun 06; 187(12):3090-3107.e21.